Precision in Point-of-Care: The Key to Patient Safety

The Revolution of Point-of-Care Diagnostics

Point-of-Care Diagnostics (POC) has revolutionized medical care. It provides results in minutes, enables fast clinical decisions, and relieves central laboratories. The use of Lateral Flow Tests (LFT) – known as 'rapid tests' – has become particularly popular. Their simplicity and speed are undisputed, but their reliability depends largely on correct, validated evaluation.

The challenge is to transfer the analytical precision of the central laboratory to the decentralized environment. This requires the validation of LFTs to go beyond the manufacturer's primary performance data (such as general sensitivity and specificity) and consider the entire measurement chain, including the reader and the user.

1. The Human Source of Error: Inter-Reader Variability (IRV)

Originally, Lateral Flow Tests were developed for qualitative or semi-quantitative evaluation: The mere appearance of a test line (T-line) or the estimation of its intensity. However, this visual interpretation is the Achilles' heel of precision.

Subjectivity and Intraobserver Variability: The intensity of a color line is subjective. Fatigue, different lighting conditions, but also the mere momentary assessment of the examiner (intraobserver variability) can lead to different diagnoses. What is a weak positive for one person might be a negative result for another.

The Necessity of Quantitative Results: Modern therapy decisions, such as administering antibiotics for elevated CRP levels (C-reactive protein), are based on exact numerical thresholds. To transform a qualitative test execution into a quantitative, lab-compatible result, eliminating subjective evaluation is mandatory.

2. Validation in Clinical Context: More Than Just a Datasheet

Manufacturers provide data on the performance of their tests under idealized laboratory conditions. However, actual use in practice or pharmacy, often in environments with low prevalence or asymptomatic patients, requires application-specific validation.

As the practice of COVID-19 tests has shown, the detection capability of an LFT depends heavily on the patient's actual viral load. An LFT validation that goes beyond the manufacturer's mere specification must answer the following questions:

• Comparison with Gold Standard: How exactly do the quantitative values of the LFT correlate with the results of the gold standard (e.g., PCR Ct values or central laboratory devices)?
• Limit of Detection (LoD): Is the critical threshold (LoD) that the test still reliably detects reproducible in the POC environment?
• Robustness: How stable is the result across the entire measurement range (linear range)?

The Role of Automation and Calibration

Only by confirming these analytical quality criteria in clinical reality can POC diagnostics justify the trust of doctors and patients.

To ensure laboratory precision at the Point-of-Care, the use of automated LFT readers like the IglooPro is essential. These readers perform the necessary, objective evaluation, thus placing analytics on a new foundation.

A. Elimination of Variability through Objectivity: Modern readers use camera systems or fluorescence technology to objectively capture test and control lines and digitally quantify intensity ratios. The result is a numerical value with a low coefficient of variation (CV) that completely eliminates IRV.

B. The Necessary Calibration and Quality Assurance (QA): A reader is only as good as its calibration. To ensure precision across different test batches and over the device's lifetime, strict QA procedures are required:

• Batch-Specific Calibration: Each production batch of LFTs can show slight differences in reaction kinetics or membrane properties. The reader must load this batch-specific data – often automatically via barcode or RFID technology – to correctly convert the LFT-specific signal into the concentration value.
• Quality Control (QC Lock): Modern systems have mechanisms (analogous to RiliBÄK in the central laboratory) that refuse measurement if internal or external quality control (e.g., a control cassette) has not been successfully performed. This guarantees that only validated measurement results are generated.

Conclusion: The Promise of POC Diagnostics

The speed of POC diagnostics is an invaluable advantage. However, trust in this speed can only be secured through continuous quality assurance and validation. Point-of-Care diagnostics aiming for laboratory levels must mandatorily rely on the automated, calibrated, and validated evaluation of Lateral Flow Tests.

Only through the combination of a robust, calibrated reader and strict validation procedures does a rapid test become a reliable diagnostic basis.